These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2432410

  • 1. A priori delineation of a peptide which mimics a discontinuous antigenic determinant.
    Geysen HM, Rodda SJ, Mason TJ.
    Mol Immunol; 1986 Jul; 23(7):709-15. PubMed ID: 2432410
    [Abstract] [Full Text] [Related]

  • 2. The delineation of peptides able to mimic assembled epitopes.
    Geysen HM, Rodda SJ, Mason TJ.
    Ciba Found Symp; 1986 Jul; 119():130-49. PubMed ID: 2426049
    [Abstract] [Full Text] [Related]

  • 3. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR, Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F.
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [Abstract] [Full Text] [Related]

  • 4. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
    Meloen RH, Puyk WC, Meijer DJ, Lankhof H, Posthumus WP, Schaaper WM.
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
    [Abstract] [Full Text] [Related]

  • 5. Mutational analysis of discontinuous epitopes of foot-and-mouth disease virus using an unprocessed capsid protomer precursor.
    Mateu MG, Escarmís C, Domingo E.
    Virus Res; 1998 Jan; 53(1):27-37. PubMed ID: 9617767
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
    de Prat-Gay G.
    Arch Biochem Biophys; 1997 May 15; 341(2):360-9. PubMed ID: 9169027
    [Abstract] [Full Text] [Related]

  • 8. Converging antigenic structure of a recombinant viral peptide displayed on different frameworks of carrier proteins.
    Carbonell X, Benito A, Villaverde A.
    FEBS Lett; 1996 Nov 18; 397(2-3):169-72. PubMed ID: 8955340
    [Abstract] [Full Text] [Related]

  • 9. Improved mimicry of a foot-and-mouth disease virus antigenic site by a viral peptide displayed on beta-galactosidase surface.
    Benito A, Mateu MG, Villaverde A.
    Biotechnology (N Y); 1995 Aug 18; 13(8):801-4. PubMed ID: 9634810
    [Abstract] [Full Text] [Related]

  • 10. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
    Bolwell C, Clarke BE, Parry NR, Ouldridge EJ, Brown F, Rowlands DJ.
    J Gen Virol; 1989 Jan 18; 70 ( Pt 1)():59-68. PubMed ID: 2471783
    [Abstract] [Full Text] [Related]

  • 11. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.
    Geysen HM, Meloen RH, Barteling SJ.
    Proc Natl Acad Sci U S A; 1984 Jul 18; 81(13):3998-4002. PubMed ID: 6204335
    [Abstract] [Full Text] [Related]

  • 12. Direct single-step surface plasmon resonance analysis of interactions between small peptides and immobilized monoclonal antibodies.
    Gomes P, Giralt E, Andreu D.
    J Immunol Methods; 2000 Feb 21; 235(1-2):101-11. PubMed ID: 10675762
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV, Samuel AR, Pullen L, Ansell D, Butcher RN, Parkhouse RM.
    J Gen Virol; 1998 Jul 21; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [Abstract] [Full Text] [Related]

  • 15. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.
    Parry N, Fox G, Rowlands D, Brown F, Fry E, Acharya R, Logan D, Stuart D.
    Nature; 1990 Oct 11; 347(6293):569-72. PubMed ID: 1699132
    [Abstract] [Full Text] [Related]

  • 16. Epitope mapping of the outer structural protein VP1 of three different serotypes of foot-and-mouth disease virus.
    Meloen RH, Barteling SJ.
    Virology; 1986 Feb 11; 149(1):55-63. PubMed ID: 2418582
    [Abstract] [Full Text] [Related]

  • 17. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
    Crossey E, Frietze K, Narum DL, Peabody DS, Chackerian B.
    PLoS One; 2015 Feb 11; 10(7):e0132560. PubMed ID: 26147502
    [Abstract] [Full Text] [Related]

  • 18. [Synthetic immunogenic complexes containing a peptide from the surface protein of the foot-and-mouth disease virus].
    Rar VA, Makarov EA, Iurovskiĭ VV, Meshcheriakova EA, Andronova TM, Ivanov VT.
    Bioorg Khim; 1990 Jul 11; 16(7):904-15. PubMed ID: 2173604
    [Abstract] [Full Text] [Related]

  • 19. Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides.
    Ferguson M, Reed SE, Minor PD.
    J Gen Virol; 1986 Nov 11; 67 ( Pt 11)():2527-31. PubMed ID: 2431104
    [Abstract] [Full Text] [Related]

  • 20. Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein.
    Geysen HM, Barteling SJ, Meloen RH.
    Proc Natl Acad Sci U S A; 1985 Jan 11; 82(1):178-82. PubMed ID: 2578661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.